⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4817 | 0.91 | — | — | |
| SCHEMBL5310 | 0.87 | — | — | |
| Charcoal, Activated SCHEMBL4759885 | 0.83 | — | — | |
| SCHEMBL122688 | 0.82 | — | — | |
| SCHEMBL5041 | 0.82 | — | — | |
| SCHEMBL286828 | 0.82 | — | — | |
| SCHEMBL16694121 | 0.82 | — | — | |
| SCHEMBL62295 | 0.82 | — | — | |
| SCHEMBL131111 | 0.82 | — | — | |
| SCHEMBL287204 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5328 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024151919-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | IFM DUE, INC. (US) | 2024-07-18 | — | — | WO | claimed |
| CN-113227089-B | Substituted 6-azabenzimidazole compounds as HPK1 inhibitors | 吉利德科学公司 | 2024-07-05 | — | — | CN | claimed |
| US-20240218282-A1 | ETHYLENE-PROPYLENE BRANCHED COPOLYMERS USED AS VISCOSITY MODIFIERS | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2024-07-04 | — | — | US | claimed |
| EP-4384503-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | IFM Due, Inc. (US) | 2024-06-19 | — | — | EP | claimed |
| WO-2024120442-A1 | PAK4 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | CONVERGEN (SUZHOU) PHARMACEUTICAL CO., LTD. (CN) | 2024-06-13 | — | — | WO | claimed |
| US-12005054-B2 | Piperidinyl-3-(aryloxy)propanamides and propanoates | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2024-06-11 | — | — | US | claimed |
| EP-4379838-A1 | SECONDARY BATTERY, AND BATTERY MODULE, BATTERY PACK AND ELECTRIC DEVICE COMPRISING SAME | Contemporary Amperex Technology Co., Limited (CN) | 2024-06-05 | — | — | EP | claimed |
| CN-118119595-A | Compounds and compositions for the treatment of diseases associated with STING activity | 艾福姆德尤股份有限公司 | 2024-05-31 | — | — | CN | claimed |
| CN-117940438-A | Heterocyclic compounds as MAP4K1 inhibitors | 缆图药品公司 | 2024-04-26 | — | — | CN | claimed |
| WO-2024064358-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | IFM DUE, INC. (US) | 2024-03-28 | — | — | WO | claimed |
| EP-0206605-A1 | N-Acyl amino acid derivative and process for production and use thereof | SUNTORY LIMITED (JP) | 1986-12-30 | — | — | EP | claimed |
| US-4500526-A | ANTIBIOTICS, BACTERICIDES | BRISTOL-MYERS COMPANY (US) | 1985-02-19 | — | — | US | claimed |
| US-4385177-A | Cephalosporins having a carbamoylalkoxyiminoarylacetamido group at 7-position | GLAXO LABORATORIES, LTD. (GB) | 1983-05-24 | — | — | US | claimed |
| US-4315005-A | Cephalosporin antibiotics | GLAXO GROUP LIMITED (GB) | 1982-02-09 | — | — | US | claimed |
| US-4190656-A | VIRICIDES, ANTITUMOR AGENTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1980-02-26 | — | — | US | claimed |
| US-4168309-A | Cephalosporins having a 7-(carboxy substituted α-etherified oximinoarylacetamido) group | GLAXO LABORATORIES LIMITED (GB) | 1979-09-18 | — | — | US | claimed |
| US-4165430-A | HIGH ACTIVITY AGAINST GRAMNEGATIVE BACTERIA | GLAXO LABORATORIES LIMITED (GB) | 1979-08-21 | — | — | US | claimed |
| US-4144393-A | 3-Acetoxymethyl cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyiminoarylacetamido group | GLAXO LABORATORIES LIMITED (GB) | 1979-03-13 | — | — | US | claimed |
| US-4144392-A | Cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyimino-arylacetamido group and at position-3 the residue of a sulphur nucleophile | GLAXO LABORATORIES LIMITED (GB) | 1979-03-13 | — | — | US | claimed |
| US-4103084-A | ANTIBIOTICS | GLAXO LABORATORIES LIMITED (GB) | 1978-07-25 | — | — | US | claimed |